Variant position: 624 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 1043 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human GMGDVSEKHGSGPVVPEKAV RFSFTIMKITI--AHSSQNVKVF
Mouse GMGDVSEKHGSGPAVPEKAV RFSFTVMRITI--EHGSQNVK
Pig GMGDVSEKHGSGPVVPEKAV RFSFTVMKITI--AHGSQNVK
Rabbit GMGDVTEKHGSGPAVPEKAV RFSFTVMKITI--AHGSQNVK
Chicken GMGDVSEKHGSGPAVPEKAV RFSFTVMNIAI--DHENERIR
Xenopus laevis GMGDVSEKHGSGPPVPEKAV RFSFTVMNISV--PNKNGPVR
Zebrafish GMGDVSEKHGSGPAVPEKAV RFSFTIMSISIRLEGEDDGIT
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 1043 V(D)J recombination-activating protein 1
V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations.
Villa A.; Sobacchi C.; Notarangelo L.D.; Bozzi F.; Abinun M.; Abrahamsen T.G.; Arkwright P.D.; Baniyash M.; Brooks E.G.; Conley M.E.; Cortes P.; Duse M.; Fasth A.; Filipovich A.M.; Infante A.J.; Jones A.; Mazzolari E.; Muller S.M.; Pasic S.; Rechavi G.; Sacco M.G.; Santagata S.; Schroeder M.L.; Seger R.; Strina D.; Ugazio A.; Vaeliaho J.; Vihinen M.; Vogler L.B.; Ochs H.; Vezzoni P.; Friedrich W.; Schwarz K.;
Cited for: VARIANTS OS TYR-328; LEU-396; PRO-401; VAL-435; SER-559; CYS-624; GLY-669 AND GLN-975; VARIANTS OS/T(-)B(-)NK(+) SCID GLN-410; MET-433; VAL-444; HIS-474; TRP-507; CYS-522 AND LEU-753; VARIANT IMMUNODEFICIENCY ILE-855;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.